In this episode of MarketFoolery, host Chris Hill chats with Fool.com contributor Dan Kline about the latest headlines and earnings reports from Wall Street. They go through Tencent's numbers to find out how some of its divisions have performed during the quarter and over the year.
Snatching up TikTok would capture the short-form video platform’s 100 million U.S. users and give Twitter a chance to capitalize on lessons it learned with the demise of Vine.
CureVac BV said on Friday it raised $213.3 million in its initial public offering in New York, setting the stage for the first stock market debut of a company developing a potential vaccine to combat the coronavirus. The German biotechnology firm, backed by Microsoft Corp founder and billionaire Bill Gates, sold 13.33 million shares at $16 apiece, the top end of its indicated price range of between $14 and $16 per share. CureVac is researching how to use messenger RNA to treat a series of diseases, including the coronavirus.